This is not the most recent version of the article. View current version (7 SEP 2011)

Intervention Protocol

Angiogenesis-inhibitors for the treatment of ovarian cancer

  1. Kezia Gaitskell1,*,
  2. Igor Martinek2,
  3. Shibani Nicum3,
  4. Sean Kehoe2,
  5. Jo Morrison4

Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 8 JUL 2009

DOI: 10.1002/14651858.CD007930


How to Cite

Gaitskell K, Martinek I, Nicum S, Kehoe S, Morrison J. Angiogenesis-inhibitors for the treatment of ovarian cancer (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD007930. DOI: 10.1002/14651858.CD007930.

Author Information

  1. 1

    UCL Medical School, North Central Thames Foundation School, London, UK

  2. 2

    Oxford Cancer and Haematology Centre, Oxford Gynaecological Oncology Centre, Level 0, Oxford, UK

  3. 3

    Oxford Cancer and Haematology Centre, NHS Department of Oncology, Level 2, Oxford, UK

  4. 4

    University of Oxford, Nuffield Department of Obstetrics and Gynaecology, Oxford, UK

*Kezia Gaitskell, North Central Thames Foundation School, UCL Medical School, Royal Free School, Rowland HiIll Street, London, NW3 2PF, UK. gaitskell@doctors.org.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 8 JUL 2009

SEARCH

This is not the most recent version of the article. View current version (07 SEP 2011)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To compare the effectiveness and harmful effects of interventions, which inhibit angiogenesis, in the treatment of ovarian cancer.